Spectroplast AG has developed a high-precision 3D printing technology for pure silicone, enabling the production of complex soft medical implants. Spectroplast’s Silicones are compatible with the latest SLA and DLP Technology, innovation lies in providing a cutting-edge material technology that makes industry-standard Silicones accessible to Additive Manufacturing.
According to Johann Oberhofern and Manuel Schaffner, Chief Technology Officer at Spectroplast, TCT Magazine, AM Ventures,” introduction of silicones to the world of additive manufacturing is well-timed with the rapidly growing demand for customized silicone products that we not only observe in the healthcare sector but also in many other markets.
As an industry, we are just starting to understand how powerful 3D printing of functional products will become when it is combined with the massive potential offered by industrial-scale production. Having the financial support and domain expertise of AMV will help us execute our mission even more rapidly and broadly.”
This entry was posted in 3D /4D Printing Medical Technology/Dental/Orthopedics/ Pharmaceuticals/ Implants/ Invisiline/Dentures/ Virtual Reality., 3D Printing Construction Technology/ Real Estate/ Housing/Architecture/ Challenges., 3D Printing/4D Printing /Biotechnology/Robotics., 3D Printing/Fashion/ Jewelry/Art/Design/Creativity., 3D Printing/Patent/AI/Science/Fans of the Day/VR., 3D/4D/5D Printing emergence., Policy. and tagged AM Ventures, €1.4m investment, Health, Johann Oberhofern, Manuel Schaffner, Spectroplast, Spectroplast silicone 3D printing got €1.4m investment from AM Ventures, TCT Magazine.